Dalton, Greiner, Hartman, Maher & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
SCM
SAM
Dalton, Greiner, Hartman, Maher & Co's MDRX Position: Q1 2019 in Review
Dalton, Greiner, Hartman, Maher & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2019, closing a stake of 2,469,973 shares — an estimated $23.8M sold.
Dalton, Greiner, Hartman, Maher & Co first reported a position in MDRX in Q2 2017 and held it in 7 quarters. The position peaked at $46.3M in Q3 2018. 225 funds tracked by Wall St. Rank hold MDRX as of Q1 2019.
- Dalton, Greiner, Hartman, Maher & Co reported no remaining Veradigm Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
- Dalton, Greiner, Hartman, Maher & Co sold 2,469,973 Veradigm Inc. Common Stock shares in Q1 2019, an estimated $23.8M.
- Dalton, Greiner, Hartman, Maher & Co first reported a position in Veradigm Inc. Common Stock in Q2 2017 and held it in 7 quarters.
- Dalton, Greiner, Hartman, Maher & Co's Veradigm Inc. Common Stock position peaked at $46.3M in Q3 2018.
- 225 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2019.
Based on Dalton, Greiner, Hartman, Maher & Co's 13F filing for Q1 2019, filed 8 Apr 2019.